Treating cancer using electromagnetic fields in combination with other treatment regimens
View Patent ↗Chemotherapeutic treatment for certain cancers may be combined with low intensity, intermediate frequency alternating electric fields that are tuned to a particular type of target cell. When the tuned fields were combined with Paclitaxel, Doxorubicin or Cyclophosphamide, excellent results were obtained against human breast cancer cells (MDA-MB-231) and non-small cell lung (H1299) carcinomas in culture. More specifically, cell proliferation inhibition similar to that obtained by drug alone was reached by exposure to the combined treatment at drug concentrations between one and two orders of magnitude lower than for drug-only regimens of treatment.
1. A method of killing or inhibiting the growth of cancer cells in a target region, the method comprising the steps of:
applying, to the target region, an AC electric field that damages the cancer cells or inhibits the growth of the cancer cells, but leaves normal cells in the target region substantially unharmed, wherein the electric field has a frequency between 50 kHz and 500 kHz and wherein the direction of the field is changed in an alternating sequence by applying the field between different sets of electrodes; and
treating the cancer cells with an other anti-cancer regimen, wherein the applying step and the treating step are performed simultaneously.
2. The method of claim 1 , wherein the other anti-cancer regimen comprises treating the cancer cells with an anti-cancer drug.
3. A method of killing or inhibiting the growth of cancer cells in a target region, the method comprising the steps of:
applying, to the target region, an electric field that damages the cancer cells or inhibits the growth of the cancer cells, but leaves normal cells in the target region substantially unharmed; and
treating the cancer cells with an anti-cancer drug, wherein the applying step and the treating step are performed simultaneously, and wherein the drug comprises at least one of Paclitaxel, Doxorubicin, Cyclophosphamide, and Cisplatin.
4. A method of killing or inhibiting the growth of cancer cells in a target region, the method comprising the steps of:
applying, to the target region, an electric field that damages the cancer cells or inhibits the growth of the cancer cells, but leaves normal cells in the target region substantially unharmed; and
treating the cancer cells with an anti-cancer drug, wherein the applying step and the treating step are performed simultaneously, and wherein the drug dosage is less than 20% of a standard dosage for the drug.
5. A method of inhibiting the growth of cancer cells in a target region, the method comprising the steps of:
treating the cancer cells with an anti-cancer drug; and
applying an AC electric field to the target region for a period of time, wherein the electric field has frequency and field strength characteristics selected to inhibit the growth of cancer cells in the target region and wherein the electric field has a frequency between 50 kHz and 500 kHz and wherein the direction of the field is changed in an alternating sequence by applying the field between different sets of electrodes.
6. A method of inhibiting the growth of cancer cells in a target region, the method comprising the steps of:
treating the cancer cells with an anti-cancer drug; and
applying an electric field to the target region for a period of time, wherein the electric field has frequency and field strength characteristics selected to inhibit the growth of cancer cells in the target region, and
wherein the drug dosage is less than 20% of a standard dosage for the drug.
7. The method of claim 5 , wherein the period of time is at least 24 hours.
8. The method of claim 5 , wherein the field strength is at least 1 V/cm.
9. A method of inhibiting the growth of cancer cells in a target region, the method comprising the steps of:
treating the cancer cells with an anti-cancer drug; and
applying an AC electric field to the target region for a period of time, wherein the electric field has frequency and field strength characteristics selected to inhibit the growth of cancer cells in the target region, and
wherein the drug comprises at least one of Paclitaxel, Doxorubicin, Cyclophosphamide, and Cisplatin.
10. The method of claim 9 , wherein the field strength of the electric field is at least 1 V/cm and the period of time is at least 24 hours.
11. The method of claim 10 , wherein the frequency of the electric field is about 150 kHz.
12. The method of claim 10 , wherein the frequency of the electric field is about 200 kHz.
13. A method of killing or inhibiting the growth of cancer cells in a target region, the method comprising the step of
Applying, an AC electric field that damages the cancer cells or inhibits the growth of the cancer cells, but leaves normal cells in the target region substantially unharmed, wherein the AC electric field is applied while the cancer cells are being treated with an anti-cancer drug,
wherein the electric field has frequency between about 100 kHz and 300 kHz, and a field strength in the target region of at least 1 V/cm and wherein the direction of the field is changed in an alternating sequence by applying the field between different sets of electrodes.
14. The method of claim 13 , wherein the drug comprises Cyclophosphamide.
15. The method of claim 14 , wherein the period of time is at least 6 hours.
16. The method of claim 15 , wherein the frequency is about 150 kHz.
17. The method of claim 15 , wherein the frequency is about 200 kHz.
18. The method of claim 13 , wherein the drug dosage is less than 20% of a standard dosage for the drug.
19. The method of claim 13 , wherein the period of time is at least 24 hours.
20. The method of claim 13 , wherein the drug comprises at least one of Paclitaxel, Doxorubicin, Cyclophosphamide, and Cisplatin.
21. The method of claim 13 , wherein the field strength is between 1 V/cm and 5 V/cm and the period of time is at least 24 hours.
22. The method of claim 21 , wherein the frequency is about 150 kHz.
23. The method of claim 21 , wherein the frequency is about 200 kHz.